Clinical trials with gene-editing tools to start: Tang Prize laureate
04/22/2018 06:50 PM
Chinese American biologist and 2016 Tang Prize winner in biopharmaceutical science Feng Zhang (張鋒) said Saturday that initial clinical trials using gene-editing technology to help people with genetic diseases are expected to start this year or next.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Ted Cruz again proposes allowing Taiwan servicemen to wear uniforms in U.S.
10/21/2025 11:23 AM - Society
Torrential rain forecast for Taipei mountain areas Tuesday
10/21/2025 10:33 AM - Business
U.S. dollar down in Taipei trading
10/21/2025 10:09 AM - Society
Taiwan headline news
10/21/2025 09:59 AM - Business
Taiwan shares open higher
10/21/2025 09:10 AM